Icon plc Stock
Price
Target price
€162.85
€162.85
0.800%
1.3
0.800%
€201.09
14:12 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
The Icon plc stock is trending slightly upwards today, with an increase of €1.30 (0.800%) compared to yesterday's price.
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 201 € there is a positive potential of 23.43% for Icon plc compared to the current price of 162.85 €.
Pros and Cons of Icon plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.800% | 4.259% | 1.222% | -24.012% | 4.259% | -14.524% | - |
| Alkermes plc | 0.000% | 5.085% | -1.587% | -9.489% | 5.085% | 3.722% | 45.882% |
| Novocure Ltd | 3.610% | 12.660% | 23.144% | -54.425% | 12.660% | -87.532% | -90.836% |
| Ironwood Pharmaceuticals | 0.000% | 30.827% | 19.178% | -19.444% | 30.827% | -70.588% | -63.750% |
Comments
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
News
3 Healthcare Pathbreakers With Long-Term Tailwinds
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals
